|
Vaccine Detail
Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155 |
Vaccine Information |
- Vaccine Name: Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Vaccine Ontology ID: VO_0004302
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- NP
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pVAX1 expressed nucleoprotein (NP) specific CTL epitope (NP147–155) (Tao et al., 2009).
- Detailed Gene Information: Click Here.
- HA
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pVAX1 expressed surface proteins hemagglutinin (HA) (Tao et al., 2009).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000024
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Mice vaccinated with pHA/NP147–155 had significantly reduced lung viral titers, compared with control mice vaccinated with the pVAX1vector. Our data showed that vaccination of mice with pHA/NP147–155 induced the enhanced protection against H5N1 influenza virus infection in BALB/c mice, suggesting that it is feasible to use DNA vaccines that express multiple epitopes to fight against H5N1 influenza viruses. the enhanced protection against the H5N1 influenza virus by pHA/NP147–155 vaccination was dependent on the recognition of the H-2d dominant CD8+ T cell epitope in mice (Tao et al., 2009).
|
References |
Tao et al., 2009: Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Antiviral research. 2009; 81(3); 253-260. [PubMed: 19135483].
|
|